Conexeu Sciences (Direct Listing)
Note: This is NOT an IPO. This is a NASDAQ Direct Listing. The company sold some stock in a private placement at $4.00 per share on March 25, 2026. H.C. Wainwright is the financial advisor for the NASDAQ Direct Listing. We are an early-stage biotech company with a limited operating history. We have developed a […]
May 18, 2026 Read More